This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Kazuhiro Morishita, MD; Hideki KODO, MD; Shigetaka Asano, MD; Hisaichi Fujii, MD; Shigeo Miwa, MD
The Tokyo University Bone Marrow Transplantation Team Institute of Medical Science University of Tokyo

JAMA. 1985;253(4):511.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

As the cases of bone marrow transplantation (BMT) are accumulating, viral infection such as cytomegalovirus emerges as one of the major problems.¹ However, other viral agents should not be ignored since infection is sometimes fatal if visceral dissemination occurs. In varicella zoster virus (VZV) infection, death caused by encephalitis or interstitial pneumonitis has been reported.² Recently, we have experienced a rare case of VZV infection terminating in fulminant hepatitis associated with disseminated intravascular coagulation.

Report of a Case.—

A 40-year-old Japanese man was diagnosed as having acute myeloblastic leukemia (M2 in the French-American-British cooperative group classification). Complete remission was obtained by two courses of chemotherapy with daunorubicin, cytarabine, mercaptopurine, and prednisolone, but six months after diagnosis, he relapsed with CNS involvement. A second complete remission was obtained following two courses of chemotherapy with benzoyl-cytarabine, aclarubicin, mercaptopurine, and prednisolone and intrathecal methotrexate infusion, and BMT from . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?